- Esteemed for its oncological expertise, the Baselga Institute of Oncology collaborates with American cancer centers to advance melanoma treatment.
- Utilizes surgical excision, immunotherapy, and targeted therapies for melanoma management.
- Dr. Jesus Soberino specializes in immunotherapy for melanoma, with a focus on Pembrolizumab and Nivolumab/Ipilimumab treatments.
- Dr. Soberino's experience includes phase 1-3 clinical trials that have resulted in the approval of novel melanoma medications.
- As a member of the Melanoma Unit at the Vall d'Hebron University Hospital, Dr. Soberino is dedicated to improving patient outcomes.
accreditations:
Consultation with an oncologist | $809.8 |
Histopathology revision | $1036.55 |